Real-time continuous glucose monitoring (CGM) has a potential role in preventing hypoglycemia and overcoming barriers to the implementation of intensive diabetes therapy.
Does real-time continuous glucose monitoring prevent hypoglycemia in patients on intensive diabetes therapy?
Real-time continuous glucose monitoring may play a role in preventing hypoglycemia and overcoming barriers to intensive diabetes therapy.
Intensive diabetes therapy is complicated by an increased rate of hypoglycemia and the development of hypoglycemia unawareness. This presentation focuses on the potential role of real-time continuous glucose monitoring (CGM) in preventing hypoglycemia, and in overcoming this barrier to the implementation of intensive therapy. Issues to be discussed include the differences between capillary blood and interstitial glucose levels, the impact of lag times on sensor calibration and accuracy, and the importance of patient education in minimizing the risk for hypoglycemia from uncontrolled postprandial bolusing.
Howard Wolpert (Mon,) conducted a review in Diabetes with hypoglycemia. Real-time continuous glucose monitoring (CGM) was evaluated. Real-time continuous glucose monitoring (CGM) has a potential role in preventing hypoglycemia and overcoming barriers to the implementation of intensive diabetes therapy.